| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,411,000 | 2,331,000 | 2,160,000 | 3,308,000 | | Cost of Revenue |
-
| 54,000 | 65,000 | 214,000 | | | Gross Profit |
-
| 2,277,000 | 2,095,000 | 3,094,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,436,000 | 1,318,000 | 1,253,000 | 1,934,000 | | Non Recurring | 261,000 | 28,000 | 1,000 | 333,000 | | Others | 52,000 | 48,000 | 118,000 | 95,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 883,000 | 723,000 | 732,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 781,000 | 883,000 | 723,000 | 732,000 | | Interest Expense |
-
| 139,000 | 109,000 | 370,000 | | Income Before Tax | 487,000 | 744,000 | 614,000 | 362,000 | | Income Tax Expense | 160,000 | 242,000 | 138,000 | 106,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 327,000 | 502,000 | 476,000 | 256,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
| (3,684,000) |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 327,000 | (3,182,000) | 476,000 | 256,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| (22,000) | | | Net Income Applicable To Common Shares | $164,000 | ($3,182,000) | $476,000 | $234,000 |
|
0.01% Nasdaq 
0.22%
Income Statement
